A new clinical trial for Ebola treatment is underway in the Democratic Republic of Congo (DRC) to improve survival rates for patients in eastern regions. According to the World Health …
Medication
-
-
The 2018–2020 Ebola outbreak in the Democratic Republic of the Congo (DRC) marked a turning point in medical history, as researchers successfully validated two life-saving treatments through a randomized controlled …
-
Researchers will be testing if two drugs could improve survival. One is Gilead Sciences’ remdesivir, a broad-acting antiviral approved to treat COVID-19 but that has shown some hints in lab …
-
Cystinosis is a rare, genetic lysosomal storage disorder characterized by the abnormal accumulation of the amino acid cystine within cells, which leads to widespread organ damage. According to the National …
-
Ebola Outbreak in Congo Claims Third Orphanage Death, Spreading Amid Rising Cases At least three children have died from Ebola at a facility in the Democratic Republic of the Congo, …
-
Understanding GLP-1 Receptor Agonists: Clinical Uses and Current Landscape Glucagon-like peptide-1 (GLP-1) receptor agonists, including medications like semaglutide and tirzepatide, have transformed the treatment landscape for type 2 diabetes and …
-
Understanding Alpha-gal Syndrome: The Tick-Borne Red Meat Allergy Alpha-gal syndrome (AGS) is a serious, potentially life-threatening allergic condition triggered by the bite of a lone star tick, according to the …
-
Regeneron’s Maftivimab, Mapp’s MBP134, and Gilead’s Remdesivir Highlight Ongoing Efforts in Antiviral Development Regeneron’s monoclonal antibody maftivimab, Mapp Biopharmaceuticals’ MBP134, and Gilead Sciences’ remdesivir are among the therapies being prioritized …
-
Therapeutic Animal Interventions: The Role of Donkeys in Mental Health Care The integration of animals into psychiatric treatment has evolved significantly, moving beyond traditional pet therapy to include a wider …
-
Ebola Outbreak Update: WHO Director-General Highlights Recoveries in Eastern Congo In a significant development for public health in eastern Congo, the World Health Organization (WHO) has confirmed that five patients …